Junshi Biosciences (01877.HK) signs "Authorization License Agreement" with Fosun Pharma

Wealth China Financial APP News, Junshi Biosciences (01877.HK) announced that on June 30, 2026, Shanghai Junshi Biosciences Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") signed a "License Agreement" with Fosun Pharma, a wholly-owned subsidiary of Shanghai Fosun Pharma (Group) Co., Ltd. (Fosun Pharma). Fosun Pharma (Jiangsu) Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of Fosun Pharma, also known as Fosun Wanbang.